05/04/2019
I wanted to thank those of you who have been so attentive in following our information regarding Testosterone Replacement Therapy Heart Attack lawsuits. With the litigation on those particular medications nearing a close, I wanted to shed light on some medications that have been recently associated with an increased risk for Heart Attacks and other cardiovascular events - namely the Gout medication Uloric, and the Diabetic Drug Onglyza. Please read the article I have linked below to learn more about the Gout Medication Uloric, and how the FDA recently mandated a change to its warning label.
The FDA recently released a sdrug afety communication for Uloric, a gout medication manufactured by Takeda Pharmaceuticals. Prior to this safety communication, the FDA had notified the public they were evaluating Uloric for possible connections to an increase risk of heart-related deaths. After a mo...
